Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C

by Andrew Hill, Bryony Simmons, Dzintars Gotham, Joseph Fortunak
Published 2016-01-01

Minimum costs to manufacture new treatments for COVID-19

by Andrew Hill, Junzheng Wang, Jacob Levi, Katie Heath, Joseph Fortunak
Published 2020-04-01

Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries

by Andrew Hill, Dzintars Gotham, Graham Cooke, Sanjay Bhagani, Isabelle Andrieux-Meyer, Jennifer Cohn, Joseph Fortunak
Published 2015-04-01